Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor
Guangzhou Municipal Science and Technology Bureau, China [201604020017]; Science and Technology Planning Project of Guangdong Province [2014A020221046, 2014A020221113, 2017B030314166]
第一作者机构：[1]Oncology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China
通讯作者：
通讯机构：[1]Oncology, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China
推荐引用方式(GB/T 7714)：
Zhu Y-J.,Zhang H-B.,Chang X-S.,et al.Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor[J].ANNALS OF ONCOLOGY.2020,31:S290-S290.doi:10.1016/j.annonc.2020.08.246.
APA：
Zhu, Y-J.,Zhang, H-B.,Chang, X-S.,Xiao, Z-Z.,Liu, L-R.&Liu, Y-H..(2020).Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor.ANNALS OF ONCOLOGY,31,
MLA：
Zhu, Y-J.,et al."Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor".ANNALS OF ONCOLOGY 31.(2020):S290-S290
医学